| 1. |
Wei J, Zhang Y, Zheng J, et al. Prognostic value of ABO blood group in a Chinese population in Northwest China region with curatively resected rectal cancer. J Cancer, 2019, 10(26): 6584-6593.
|
| 2. |
Cao X, Wen ZS, Sun YJ, et al. Prognostic value of ABO blood group in patients with surgically resected colon cancer. Br J Cancer, 2014, 111(1): 174-180.
|
| 3. |
汪曉東, 劉健博, 李立. 數據庫建設第五部分·結直腸癌的腫瘤特征—模塊的設計 (二). 中國普外基礎與臨床雜志, 2020, 27(4): 483-488.
|
| 4. |
汪曉東, 劉健博, 李立. 數據庫建設第六部分: 結直腸癌分期的標簽與結構化. 中國普外基礎與臨床雜志, 2020, 27(7): 873-879.
|
| 5. |
汪曉東, 朱佳怡, 李立. 數據庫建設第十一部分: 結直腸癌隨訪的標簽與結構化. 中國普外基礎與臨床雜志, 2021, 28(10): 1353-1359.
|
| 6. |
周嘉茗, 陳希, 林容若, 等. 結直腸癌患者年齡與住院流程的關系: 基于DACCA的真實世界數據研究. 中國普外基礎與臨床雜志, 2022, 29(8): 1073-1077.
|
| 7. |
Zhang BL, He N, Huang YB, et al. ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 2014, 15(11): 4643-4650.
|
| 8. |
Urun Y, Ozdemir NY, Utkan G, et al. ABO and Rh blood groups and risk of colorectal adenocarcinoma. Asian Pac J Cancer Prev, 2012, 13(12): 6097-6100.
|
| 9. |
Nakagoe T, Nanashima A, Sawai T, et al. Expression of blood group antigens A, B and H in carcinoma tissue correlates with a poor prognosis for colorectal cancer patients. J Cancer Res Clin Oncol, 2000, 126(7): 375-382.
|
| 10. |
Luo Q, Pan M, Feng H, et al. ABO blood group antigen therapy: a potential new strategy against solid tumors. Sci Rep, 2021, 11(1): 16241.
|
| 11. |
Le Pendu J, Marionneau S, Cailleau-Thomas A, et al. ABH and Lewis histo-blood group antigens in cancer. APMIS, 2001, 109(1): 9-31.
|
| 12. |
Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet, 2014, 383(9927): 1490-1502.
|
| 13. |
Zheng W, Lu Y, Feng X, et al. Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients. Cancer Med, 2021, 10(17): 5998-6009.
|
| 14. |
Ueno H, Mochizuki H, Akagi Y, et al. Optimal colorectal cancer staging criteria in TNM classification. J Clin Oncol, 2012, 30(13): 1519-1526.
|
| 15. |
Bramsen JB, Rasmussen MH, Ongen H, et al. Molecular-subtype-specific biomarkers improve prediction of prognosis in colorectal cancer. Cell Rep, 2017, 19(6): 1268-1280.
|